Sign in

openevidence.bsky.social

@openevidence.bsky.social
119 followers 35 following 47 posts
PostsRepliesMedia
Reposted by @openevidence.bsky.social
Elisabeth Bik @elisabethbik.bsky.social · 19/05/2026
Next, Mario Aquilar interviews Zachary Ziegler from @openevidence.bsky.social “OpenEvidence won the hearts of doctors. Now what?” ZZ: Evidence is the core foundation of medicine. Doctors can input a lot of data and get really personalized medicine. The website is free. #STATBreakthrough
The two men on the podium
141
Reposted by @openevidence.bsky.social
STAT @statnews.com · 18/05/2026
Join STAT correspondent Mario Aguilar and @openevidence.bsky.social to discuss how it disrupted legacy medical reference tools by winning over hundreds of thousands of clinicians with AI-powered search — and where the company goes next.
111
Reposted by @openevidence.bsky.social
STAT @statnews.com · 15/05/2026
@openevidence.bsky.social Won the Hearts of Doctors. Now What? In just a few years, it has drawn thousands of clinicians to its AI-powered search, upending decades-old reference tools. Now that it’s won over doctors, where does it go next? Join Us: statnews.com/stat-summit-... #STATBreakthrough
statnews.com
STAT Breakthrough Summit West 2026 - San Francisco, May 19
STAT Breakthrough Summit West on May 19, 2026 in San Francisco is your chance to hear from industry leaders on the latest trends at the intersection of science, medicine, and technology.
041
Reposted by @openevidence.bsky.social
Jame Abraham, MD, FACP @jameabraham.bsky.social · 08/05/2026
ascopost.com/issues/may-1... @ascocancer.bsky.social @ascopost.bsky.social @openevidence.bsky.social
111
openevidence.bsky.social @openevidence.bsky.social · 04/05/2026
I am so excited about the opportunity to work with ACOG to better understand and support clinical knowledge requirements in woman's health!
000
Reposted by @openevidence.bsky.social
Julian Barkan, DO MPH @drjulianbarkan.bsky.social · 10/02/2026
AI Did Not Help My Writing medium.com/p/ai-did-not.... But big shout out to @openevidence.bsky.social #writing #AIwriting
medium.com
AI Did Not Help My Writing
Why I will be sticking to traditional methods.
011
Reposted by @openevidence.bsky.social
Bob Wachter @bobwachter.bsky.social · 30/01/2026
Thanks to noted futurist Jeff Goldsmith for his lovely and insightful review of A GIANT LEAP in today's Health Affairs journal. "... an island of calm and thoughtful commentary in the midst of an exhausting wave of hype.... Highly recommended." www.healthaffairs.org/content/fore...
healthaffairs.org
A Voice Of Calm Amidst The AI Hype Storm | Health Affairs Forefront
Jeff Goldsmith reviews “A Giant Leap,” a thoughtful new book about how artificial intelligence is transforming health care, by Robert Wachter.
073
Reposted by @openevidence.bsky.social
Dr. Tom Frieden @drtomfrieden.bsky.social · 20/01/2026
Excited to share our team's new partnership with @openevidence.bsky.social and the Rwanda Biomedical Centre to build AI clinical decision support tools for resource-limited settings. Rwandan clinicians will help design evidence-based technology, driving better care where it's needed most.
resolvetosavelives.org
45 Rwandan Clinicians Are Helping Shape Medical AI for Low-Resource Setting
Partnership adapting OpenEvidence clinical decision support AI for Rwanda, with 45 clinicians testing and guiding customization.
121
Reposted by @openevidence.bsky.social
Paul Sax @paulsaxmd.bsky.social · 18/12/2025
Inspired by a @nejm.org piece by Drs Brian Garibaldi and Steven Russell, I add my two cents on the physical examination. Because limitations notwithstanding, it still matters. blogs.nejm.org/hiv-id-obser...
blogs.nejm.org
What Use Is the Physical Examination in Current Medical Practice?
Share Tweet Pin Mail SMS A very interesting, quite scholarly perspective appeared in the NEJM last month called, “Strategies to Reinvigorate the Bedside Clinical ...
3124
Reposted by @openevidence.bsky.social
The ASCO Post @ascopost.bsky.social · 13/11/2025
The NCCN's Clinical Practice Guidelines in Oncology to be integrated into @openevidence.bsky.social's medical AI platform so clinicians can access trusted, evidence-based cancer care recommendations for decision-making support via natural language search. ➡️https://ow.ly/QqaK50Xr3w4
132
Reposted by @openevidence.bsky.social
awesomefuture.bsky.social @awesomefuture.bsky.social · 10/11/2025
New on The Tech Glow Up from #hlth2025 40% of doctors use it. Daily. 🩺🤖 @OpenEvidence = ChatGPT for clinicians, built by Harvard AI researchers who got tired of generic search 40M papers + 20K new studies/day = knowledge overload solved! @openevidence.bsky.social
121
Reposted by @openevidence.bsky.social
openevidence.bsky.social @openevidence.bsky.social · 17/02/2025
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast: open.spotify.com/episode/121y...
open.spotify.com
EP10 Travis Zack MD, PhD and Varun Mangalick BS, Open Evidence
STAT AI: An Emergency Medicine Podcast · Episode
021
openevidence.bsky.social @openevidence.bsky.social · 01/07/2025
Happy first day! To all interns, residents, fellows, and new attendings. We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at md_community@openevidence.com
010
openevidence.bsky.social @openevidence.bsky.social · 21/06/2025
Dr. Atul Butte was laid to rest today. His large shoulders and larger vision have been foundational to all AI can and will accomplish in healthcare. His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
giving.ucsf.edu
Your gift can ignite discovery and inspire cures
What are you passionate about? Unlocking the brain’s mysteries? Battling health inequity? Donate to UCSF today, and together we will build a healthier tomorrow.
072
Reposted by @openevidence.bsky.social
The Lancet @thelancet.com · 31/05/2025
👋 Our editors are on-site at #ASCO25, Chicago. We’re excited to be part of this gathering of global cancer experts—come & meet us. ‘Contact the Editor’ details below, in-thread 🧵 @ascocancer.bsky.social
Selfie of Lancet Senior Executive Editor, Vania Wisdom, and Acting Deputy Editor at The Lancet Oncology, Kat Gourd. Both are Lancet Oncology Ambassadors, attending the American Society of Clinical Oncology (ASCO) conference in Chicago, USA.
210512
Reposted by @openevidence.bsky.social
ACOG @acog.org · 15/05/2025
Hello from the City of Lakes! We’re thrilled to welcome thousands of members of the ob-gyn community to the 2025 Annual Clinical & Scientific Meeting. From the heart of the Midwest, we’re kicking off a weekend of connection, learning, and inspiration. Share the excitement using #ACOG2025!
192
Reposted by @openevidence.bsky.social
Joseph Yaroch @jcyaroch.bsky.social · 13/05/2025
As for the safety, I asked @openevidence.bsky.social which is a chatbot trained on the professional medical literature. The current thinking is that it is not ready for primetime. www.openevidence.com/ask/2ca4fd30...
openevidence.com
OpenEvidence
The leading medical information platform.
142
openevidence.bsky.social @openevidence.bsky.social · 30/04/2025
we are now offering free CME credits just by OE in yuour normal practice: www.openevidence.com/announcement...
openevidence.com
OpenEvidence - CME has arrived on OpenEvidence
CAMBRIDGE, MA, April 2, 2025 – We are thrilled to announce that CME is now available for free on OpenEvidence! Verified NPI users can now earn AMA PRA Category 1 Credits™.
010
Reposted by @openevidence.bsky.social
Bob Wachter @bobwachter.bsky.social · 21/03/2025
So thrilled to welcome this extraordinary group of 64 young physicians to @UCSF and @UCSFimresidency. A great day! (UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
1121
openevidence.bsky.social @openevidence.bsky.social · 22/02/2025
www.openevidence.com/announcement...
openevidence.com
OpenEvidence - OpenEvidence and NEJM Group, publisher of the New England Journal of Medicine, sign content agreement: Clinicians using OpenEvidence benefit from content sourced from NEJM Group journal...
CAMBRIDGE, MA, February 19, 2025 – OpenEvidence, the fastest-growing platform for doctors, has signed a multi-year content agreement with NEJM Group, publisher of the New England Journal of Medicine (...
010
openevidence.bsky.social @openevidence.bsky.social · 17/02/2025
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast: open.spotify.com/episode/121y...
open.spotify.com
EP10 Travis Zack MD, PhD and Varun Mangalick BS, Open Evidence
STAT AI: An Emergency Medicine Podcast · Episode
021
openevidence.bsky.social @openevidence.bsky.social · 15/02/2025
www.openevidence.com/ask/88013027...
openevidence.com
OpenEvidence - What is the evidence for cabozatinib in neuroendocrine tumors
The evidence for the use of cabozantinib in neuroendocrine tumors (NETs) is supported by several clinical studies and trials. A pivotal study published in The New England Journal of Medicine evaluated...
010
openevidence.bsky.social @openevidence.bsky.social · 08/02/2025
Some background on current limited TX options: www.openevidence.com/ask/a94c01ac... However, there is a recently opened clinical trial for this rare disease clinicaltrials.gov/study/NCT061... @jerryclee.bsky.social
clinicaltrials.gov
ClinicalTrials.gov
010
openevidence.bsky.social @openevidence.bsky.social · 07/02/2025
Some mechanistic background: www.openevidence.com/ask/07ad3d33...
openevidence.com
OpenEvidence - How are cart created and how could that lead to oncogenesis
Chimeric antigen receptor (CAR) T-cells are created through a multi-step process involving T-cell apheresis, CAR transduction, and expansion of the transduced T cells. Initially, T cells are collected...
000
openevidence.bsky.social @openevidence.bsky.social · 05/02/2025
A short review of where we were at prior to this trial www.openevidence.com/ask/1e95f6d9...
openevidence.com
OpenEvidence - What are current treatment options for hereditary angioedema
Hereditary angioedema (HAE) is managed through a combination of on-demand treatments for acute attacks and prophylactic therapies to prevent attacks. The treatment approach depends on the type of HAE,...
000
Reposted by @openevidence.bsky.social
NEJM.org @nejm.org · 04/02/2025
In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT #MedSky #Oncology
The New England Journal of Medicine    

CRISPR-Based Therapy for Hereditary Angioedema  

A PLAIN LANGUAGE SUMMARY    

Illustration of a patient with hereditary angioedema and NTLA-2002, a nonviral gene-editing therapy based on CRISPRCas9, for treatment. 

Read the full Plain Language Summary at NEJM.org.
0217
openevidence.bsky.social @openevidence.bsky.social · 05/02/2025
www.openevidence.com/ask/55b54926...
openevidence.com
OpenEvidence - What is the evidence for alcohol use and cancer
The relationship between alcohol use and cancer is well-established in the medical literature. Alcohol consumption is causally linked to several types of cancer, including cancers of the oral cavity, ...
000
Reposted by @openevidence.bsky.social
Julie Lee MD MPH • CI = AI 🤖 @drjulielee.bsky.social · 04/02/2025
As a primary care doctor & clinical informatician, I love using @openevidence.bsky.social during my clinic visits to review latest guidelines with patients & sources. I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
143
openevidence.bsky.social @openevidence.bsky.social · 04/02/2025
Other prior trials looking at the pros and cons of bridging AC peri-procedures www.openevidence.com/ask/67491f3f...
openevidence.com
OpenEvidence - What are some trials that evaluated the pros and cons of ceasing anticoagulation prior to procedures
Several trials have evaluated the pros and cons of ceasing anticoagulation prior to procedures, particularly focusing on the use of bridging anticoagulation. 1.
011
openevidence.bsky.social @openevidence.bsky.social · 01/02/2025
We do keep our index updated daily so the most recent cdc pubs and mmwr will continue to be available for answers even if removed from CDC website
011
Reposted by @openevidence.bsky.social
Eric Topol @erictopol.bsky.social · 01/02/2025
These A.I. models are rapidly changing life science. A brief, open-access review of the remarkable progress in @science.org this week www.science.org/doi/10.1126/...
science.org
Learning the language of life with AI
In 2021, a year before ChatGPT took the world by storm amid the excitement about generative artificial intelligence (AI), AlphaFold 2 cracked the 50-year-old protein-folding problem, predicting three-...
06218
openevidence.bsky.social @openevidence.bsky.social · 01/02/2025
For whom it make concern, with recent disruptions to CDC published information, we keep our index of this information updated daily, so will always have the most updated recommendations
000
Reposted by @openevidence.bsky.social
Nature @nature.com · 30/01/2025
Nature research paper: Expanding the human gut microbiome atlas of Africa go.nature.com/42x1t7S
go.nature.com
Expanding the human gut microbiome atlas of Africa - Nature
A cross-sectional study from four African countries shows the importance of investigating the gut microbiome in previously under-represented populations and provides a framework for equitable microbiome research.
15211
Reposted by @openevidence.bsky.social
Eric Topol @erictopol.bsky.social · 29/01/2025
Painful, chronic peripheral neuropathy from cancer chemotherapy is common, especially from platinum-based drugs and taxanes, as reported today in a meta-analysis of 77 studies from 28 countries
918942
Reposted by @openevidence.bsky.social
NEJM.org @nejm.org · 29/01/2025
In a 54-year-old male athlete, echocardiograms obtained 3 weeks after diagnosis of AL amyloidosis showed classic features of amyloid cardiomyopathy and evidence of progressive disease. Read the full case details: nej.md/3WpUsC8 #MedSky #CardioSky
2123
Reposted by @openevidence.bsky.social
Brett Biebelberg, MD @bbiebelberg.bsky.social · 25/01/2025
OpenEvidence. Hadn’t heard of the other two.
111